ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Pradif T, Retardtablette - 30 Tablette(n)
57160003 Boehringer Ingelheim (Schweiz) GmbH
Pradif T, Retardtablette24.06.2005
Original24.06.2005
Tamsulosin (G04CA02) 
WHO-DDD 
05.99.30 Tablette(n)
05.99. 
B  
Yes 
IPCI
21.02No
    
20 %38.70
7680571600033Synthetika
3029659 
Composition
tamsulosini hydrochloridum 400 µg corresp. tamsulosinum 367 µg, macrogolum 8000, magnesii stearas, macrogolum 7'000'000 cum E 321 et silica colloidalis hydrica, Überzug: hypromellosum, macrogolum 8000, E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Tamsulosine Hydrochloride400 µg correspond Tamsulosinum 367 µg
BAG: Active AgentDose
Tamsulosine Hydrochloride400 mcg
 
Inactive agentsDoseadditional_information
(Flavum)  
Cum E321  
E 172 color.
Hypromellosum Überzug
Macrogol8000  
Magnesii Stearas  
Pro Compresso Obducto  
Silica Colloidalis Hydrica  
 
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home